PCUS Survey 2017 PCUS Survey: Determining educational priorities in primary care urology Thank you if you participated in a previous survey led by the Primary Care Urology Society (PCUS), which provide invaluable insights into current UK practice.The purpose of this current survey is for us to understand the spectrum of educational needs related to the primary care management of urological conditions and to ask for your involvement in the development of the PCUS educational strategy. The findings from the questionnaire will also ensure study days in 2017 are focussed on the most relevant topics.We would be grateful if you could take a few minutes to complete the survey and thank you in advance for your time. Dr Jon Rees Chair, Primary Care Urology Society Question Title * 1. Name: Question Title * 2. What is your current role? GP Practice Nurse Community Urology Nurse Hospital Urology Nurse Consultant Other (please specify) Question Title * 3. Where is your current work location? (Please specify name of Surgery/Hospital & address/postcode) Question Title * 4. From the list below, in which particular condition or conditions, would you say you are currently most interested? Please try and select a maximum of 4 BPH (Benign Prostatic Hyperplasia/Enlarged Prostate) Bladder Cancer Bladder Prolapse Blood in the Urine ED (Erectile Dysfunction) Incontinence Interstitial Cystitis Kidney Cancer Kidney and Ureteral Stones Nocturia Overactive Bladder (OAB) Peyronie's Disease Prostate Cancer Prostatitis (Infection of the Prostate) STIs (Sexually Transmitted Infections) Testosterone Deficiency Urinary Tract Infections in Adults Urinary Tract Infections in Children General Men's Health, including issues beyond urology Other (please specify) Question Title * 5. For each of the conditions listed, where do you feel you may be currently lacking knowledge? Background/pathophysiology/aetiology Diagnosis Treatment options Monitoring Follow-up When to refer Managing co-morbidities Latest developments Erectile Dysfunction (ED) Erectile Dysfunction (ED) Background/pathophysiology/aetiology Erectile Dysfunction (ED) Diagnosis Erectile Dysfunction (ED) Treatment options Erectile Dysfunction (ED) Monitoring Erectile Dysfunction (ED) Follow-up Erectile Dysfunction (ED) When to refer Erectile Dysfunction (ED) Managing co-morbidities Erectile Dysfunction (ED) Latest developments Nocturia Nocturia Background/pathophysiology/aetiology Nocturia Diagnosis Nocturia Treatment options Nocturia Monitoring Nocturia Follow-up Nocturia When to refer Nocturia Managing co-morbidities Nocturia Latest developments Overactive Bladder (OAB) Overactive Bladder (OAB) Background/pathophysiology/aetiology Overactive Bladder (OAB) Diagnosis Overactive Bladder (OAB) Treatment options Overactive Bladder (OAB) Monitoring Overactive Bladder (OAB) Follow-up Overactive Bladder (OAB) When to refer Overactive Bladder (OAB) Managing co-morbidities Overactive Bladder (OAB) Latest developments Prostate Cancer Prostate Cancer Background/pathophysiology/aetiology Prostate Cancer Diagnosis Prostate Cancer Treatment options Prostate Cancer Monitoring Prostate Cancer Follow-up Prostate Cancer When to refer Prostate Cancer Managing co-morbidities Prostate Cancer Latest developments Testosterone Deficiency Testosterone Deficiency Background/pathophysiology/aetiology Testosterone Deficiency Diagnosis Testosterone Deficiency Treatment options Testosterone Deficiency Monitoring Testosterone Deficiency Follow-up Testosterone Deficiency When to refer Testosterone Deficiency Managing co-morbidities Testosterone Deficiency Latest developments Question Title * 6. For each of the conditions listed, where do you feel you may like further education? Background/pathophysiology/aetiology Diagnosis Treatment options Monitoring Follow-up When to refer Managing co-morbidities Latest developments Erectile Dysfunction (ED) Erectile Dysfunction (ED) Background/pathophysiology/aetiology Erectile Dysfunction (ED) Diagnosis Erectile Dysfunction (ED) Treatment options Erectile Dysfunction (ED) Monitoring Erectile Dysfunction (ED) Follow-up Erectile Dysfunction (ED) When to refer Erectile Dysfunction (ED) Managing co-morbidities Erectile Dysfunction (ED) Latest developments Nocturia Nocturia Background/pathophysiology/aetiology Nocturia Diagnosis Nocturia Treatment options Nocturia Monitoring Nocturia Follow-up Nocturia When to refer Nocturia Managing co-morbidities Nocturia Latest developments Overactive Bladder (OAB) Overactive Bladder (OAB) Background/pathophysiology/aetiology Overactive Bladder (OAB) Diagnosis Overactive Bladder (OAB) Treatment options Overactive Bladder (OAB) Monitoring Overactive Bladder (OAB) Follow-up Overactive Bladder (OAB) When to refer Overactive Bladder (OAB) Managing co-morbidities Overactive Bladder (OAB) Latest developments Prostate Cancer Prostate Cancer Background/pathophysiology/aetiology Prostate Cancer Diagnosis Prostate Cancer Treatment options Prostate Cancer Monitoring Prostate Cancer Follow-up Prostate Cancer When to refer Prostate Cancer Managing co-morbidities Prostate Cancer Latest developments Testosterone Deficiency Testosterone Deficiency Background/pathophysiology/aetiology Testosterone Deficiency Diagnosis Testosterone Deficiency Treatment options Testosterone Deficiency Monitoring Testosterone Deficiency Follow-up Testosterone Deficiency When to refer Testosterone Deficiency Managing co-morbidities Testosterone Deficiency Latest developments Question Title * 7. Would you be interested in providing education - if so, in what area would you have experience? Prefer not to Yes If yes, please specify which disease area Question Title * 8. Is there anyone you would recommend for providing education to a peer group? Yes Nobody I can think of If yes, please detail name/location/experitse Question Title * 9. In terms of learning styles, which of the following do you find effective? [Please tick your priority 4] Lecture-style meetings Workshops or interactive group sessions Case-based learning Distance/online learning Peer-to-peer learning Consultant/Specialist-led learning Networking sessions Question Title * 10. In your opinion, what do you think is the greatest challenge in improving primary care management of urological conditions? Question Title * 11. Please provide any further comments/suggestions Thank you for your time This is a PCUS initiative, supported by Ferring Pharmaceuticals Ltd. NOQ/689/2017/UK, Date of Preparation: March 2017 Please note your individual responses and details will be kept confidential to PCUS and will not be divulged to any third party. Done